On Saturday, President Trump ordered import taxes on Canada, China and Mexico goods, a decision that could increase costs for economics consumers, including health care.
25% prices on imports from Canada (except energy) and Mexico, and 10% on Chinese goods come into force on Tuesday. Trump said the prices will remain in place until these countries stop the flow of fentanyl and undocumented immigrants in the United States.
China is a large producer growing in pharmaceutical ingredients, and prices could increase for finished medicines if the costs for their ingredients increase. Mexico is the main source of medical devices used in the United States, according to the industrial group Advamed. Any price increase could possibly be amortized if manufacturers move more production in the United States or other countries that are not subject to additional taxes.
This article is exclusive to stat + subscribers
Unlock this article – plus daily intelligence on Capitol Hill and the life sciences industry – in Stat +subscription.
Do you already have an account? Connect